Future Health Biobank is one of the world’s most accredited stem cell banks. Regarded by its peers as the most innovative, highly considered centre of excellence for quality and service within the stem cell banking industry. Processes in both the UK and Swiss facilities are licensed and accredited to the highest level and operate to GMP standards.
Future Health Biobank’s UK laboratory is a Human Tissue Bank, licensed by the Human Tissue Authority (HTA) and authorised by the Medicines and Healthcare products Regulatory Agency (MHRA) of the UK Department of Health.
The UK Department of Health was amongst the first government bodies in Europe to issue a specific Code of Practice to govern the activities of Human Tissue Banks, which includes Cord Blood Stem Cell Banks. The objective of this Code of Practice is to ensure that safe, reliable quality tissue is produced and supplied to the health service for treatment purposes and medical applications. It is the Gold Standard for stem cell bank operations.
AABB accreditation
AABB is the global leader in standards development, accreditation and
implementation of quality systems in transfusion medicine and cellular treatments.
Human Tissue Authority (HTA)
The HTA was created by the UK Parliament as non-departmental public body of the Department of Health,
overseen by an Authority of lay and professional members appointed by the Government
British Standards Institution (BSI)
BSI is the business standards company that helps organisations all over the world make excellence a habit.
Medicines and Healthcare products Regulatory Agency
The Medicines and Healthcare products Regulatory Agency regulates medicines,
medical devices and blood components for transfusion in the UK.
Federal Office of Public Health (OFSP)
As part of the Federal Department of Home Affairs, the Federal Office of Public Health (FOPH)
is responsible for public health in Switzerland.
Good Distribution Practice for Medicinal Products (GDP)
Good distribution practice (GDP) is the standard that a medicines distributor must meet to ensure the quality and integrity of medicinal products for human use.
Medicinal products for human use must be:
Swissmedic
Swissmedic is the Swiss authority for the licensing and monitoring of cell products.
British Standards Institution Member
Established in 1901, BSI were the world’s first National Standards Body. Today, they have 90 offices in 193 countries, helping 84,000 organisations make excellence a habit.
Cyber Essentials
Cyber Essentials is a Government-backed, industry supported scheme independently verified by a qualified assessor. The scheme focuses on the following five key areas:
